Telix Pharmaceuticals Limited (TLPPF) Operating margin 2023–2025
Telix Pharmaceuticals Limited (TLPPF) operating margin by fiscal year — reported operating income divided by reported revenue.
3.7%FY2025 · since FY2023: 3.3% → 3.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 3.7% | -7.0 pp |
| FY2024 | 10.7% | +7.4 pp |
| FY2023 | 3.3% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More TLPPF financial trends
TLPPF RevenueTLPPF Net incomeTLPPF Net marginTLPPF Gross profitTLPPF Gross marginTLPPF Operating incomeTLPPF Operating cash flowTLPPF Free cash flowTLPPF Capital expendituresTLPPF Return on equityTLPPF Stock buybacksTLPPF Dividends paidTLPPF Total assetsTLPPF Total liabilitiesTLPPF Shareholders’ equityTLPPF overview →